E xperiences from previous influenza pandemics, in particular the 2009-10 pandemic, have demonstrated that we cannot expect to contain geographically the next influenza pandemic in the location it emerges, nor can we expect to prevent international spread of infection for more than a short period. Vaccines are not expected to be available during the early stage of the next pandemic (1), and stockpiles of antiviral drugs will be limited, mostly reserved for treating more severe illnesses and for patients at higher risk for influenza complications. Therefore, nonpharmaceutical interventions (NPIs), such as social distancing (2), will be heavily relied on by health authorities to slow influenza transmission in the community, with 3 desired outcomes (Figure). The first outcome would be to delay the timing of the peak of infections to buy time for preparations in the healthcare system, the second to reduce the size of the epidemic peak so that the healthcare system is not overwhelmed, and the third to spread infections over a longer time period, enabling better management of those cases and the potential for vaccines to be used at least later in the epidemic to reduce impact. Influenza virus infections are believed to spread mainly through close contact in the community (e.g., homes, workplaces, preschool and day care centers, schools, public places), and more frequent and intense contact among children has a particularly major role in transmission (5). Social distancing measures aim to reduce the frequency of contact and increase physical distance between persons, thereby reducing the risks of person-to-person transmission. These measures have played a role in mitigating previous pandemics, including the 1918-19 pandemic (6,7), and are a key part of current pandemic preparedness plans (3,4). Although a clear biological and epidemiologic rationale supports the potential effectiveness of social distancing measures, there are few opportunities for rigorous controlled trials of community interventions against influenza. Our objective was to review the evidence base for social distancing measures, focusing on the evidence supporting the effectiveness of these measures in reducing influenza transmission in the community. Methods and Results We conducted separate systematic reviews to gather available evidence on the effectiveness of 6 measures in reducing influenza transmission in the community: isolating ill persons; contact tracing; quarantining exposed persons; school dismissals or closures; workplace measures, including workplace closures; and